Antigen self-anchoring onto bacteriophage T5 capsid-like particles for vaccine design - Archive ouverte HAL Access content directly
Journal Articles (Data Paper) NPJ vaccines Year : 2024

Antigen self-anchoring onto bacteriophage T5 capsid-like particles for vaccine design

Guy Schoehn

Abstract

The promises of vaccines based on virus-like particles stimulate demand for universal non-infectious virus-like platforms that can be efficiently grafted with large antigens. Here, we harnessed the modularity and extreme affinity of the decoration protein pb10 for the capsid of bacteriophage T5. SPR experiments demonstrated that pb10 fused to mCherry or to the model antigen ovalbumin (Ova) retained picomolar affinity for DNA-free T5 capsid-like particles (T5-CLPs), while cryo-EM studies attested to the full occupancy of the 120 capsid binding sites. Mice immunization with CLP-bound pb10-Ova chimeras elicited strong long-lasting anti-Ova humoral responses involving a large panel of isotypes, as well as CD8 + T cell responses, without any extrinsic adjuvant. Therefore, T5-CLP constitutes a unique DNA-free bacteriophage capsid able to display a regular array of large antigens through highly efficient chemical-free anchoring. Its ability to elicit robust immune responses paves the way for further development of this novel vaccination platform.
Fichier principal
Vignette du fichier
Vernhes_et_al-2024-npj_Vaccines.pdf (3.19 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Licence : CC BY - Attribution

Dates and versions

hal-04373245 , version 1 (04-01-2024)

Licence

Attribution

Identifiers

Cite

Emeline Vernhes, Linda Larbi Chérif, Nicolas Ducrot, Clément Vanbergue, Malika Ouldali, et al.. Antigen self-anchoring onto bacteriophage T5 capsid-like particles for vaccine design. NPJ vaccines, 2024, 9 (1), pp.6. ⟨10.1038/s41541-023-00798-5⟩. ⟨hal-04373245⟩
60 View
11 Download

Altmetric

Share

Gmail Facebook X LinkedIn More